Arkadios Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
34,790
+20,397
| +142% | +$1.41M | 0.07% | 296 |
|
|
2025
Q1 | $999K | Sell |
14,393
-3,011
| -17% | -$209K | 0.04% | 454 |
|
|
2024
Q4 | $1.5M | Sell |
17,404
-1,358
| -7% | -$117K | 0.08% | 242 |
|
|
2024
Q3 | $2.23M | Sell |
18,762
-283
| -1% | -$33.7K | 0.13% | 169 |
|
|
2024
Q2 | $2.72M | Buy |
19,045
+5,178
| +37% | +$739K | 0.18% | 117 |
|
|
2024
Q1 | $1.78M | Buy |
13,867
+3,222
| +30% | +$414K | 0.14% | 159 |
|
|
2023
Q4 | $1.1M | Buy |
10,645
+6,974
| +190% | +$721K | 0.09% | 204 |
|
|
2023
Q3 | $334K | Sell |
3,671
-9
| -0.2% | -$819 | 0.03% | 453 |
|
|
2023
Q2 | $298K | Sell |
3,680
-276
| -7% | -$22.3K | 0.03% | 448 |
|
|
2023
Q1 | $315K | Buy |
3,956
+498
| +14% | +$39.6K | 0.04% | 423 |
|
|
2022
Q4 | $234K | Buy |
+3,458
| New | +$234K | 0.03% | 474 |
|
|
2021
Q4 | – | Sell |
-268
| Closed | -$12K | – | 1356 |
|
|
2021
Q3 | $12K | Sell |
268
-48
| -15% | -$2.15K | ﹤0.01% | 1394 |
|
|
2021
Q2 | $13K | Buy |
316
+256
| +427% | +$10.5K | ﹤0.01% | 1457 |
|
|
2021
Q1 | $2K | Sell |
60
-348
| -85% | -$11.6K | ﹤0.01% | 1534 |
|
|
2020
Q4 | $14K | Buy |
+408
| New | +$14K | ﹤0.01% | 868 |
|
|
2020
Q2 | – | Sell |
-204
| Closed | -$6.14K | – | 1080 |
|
|
2020
Q1 | $6.14K | Buy |
+204
| New | +$6.14K | ﹤0.01% | 743 |
|